Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision Cell Immunotherapy + TACE for Advanced Liver Cancer
NCT02862613Phase 2Unknown
- Sponsor
- Shanghai International Medical Center
- Start
- Aug 2016
- Primary completion
- Mar 2018
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of precision cells in hepatocellular carcinoma (HCC), sponsored by Shanghai International Medical Center. Status: unknown.
02
Drugs
precision cells
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02862613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862613.